Earth Life Sciences Inc
Change company Symbol lookup
Select an option...
CLTS Earth Life Sciences Inc
CYBN Cybin Inc
LEN.B Lennar Corp
STLD Steel Dynamics Inc
GOEVW Canoo Equity Warrant Exp 21st Dec 2025 *W EXP 12/21/2025
GNBT Generex Biotechnology Corp
MFA MFA Financial Inc
GOOG Alphabet Inc
ADILW Adial Pharmaceuticals Equity Warrants Exp 31 July 2023 *W EXP 07/31/2023
MBDC Massachusetts Business Development Corp

Based in Canada
Company profile

Earth Life Sciences Inc. is a healthcare company. The Company through its subsidiary, VIVA Health HK Limited (Viva Health), is engaged in providing health services primarily in the United States. Viva Health is focused on building a platform in the United States, which optimizes the functions of health care staff training management, health care service management and quality control, and providing a range of services in the United States, and particularly for aging Asian families. Through its artificial intelligence (AI), the Company seeks to assist in the customization and implementation of a software platform, which facilitates the delivery of onsite lifestyle services and well-being to families across the United States under the banner of VIVA USA. The Company through, Anhutong Healthcare Platform, provides a one stop smart healthcare service brand in the healthcare industry.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Bed Bath & Beyond stock snaps longest win streak in 15 years after Baird analyst suggests it's time to sell

7:46 am ET August 10, 2022 (MarketWatch)

By James Rogers

Fellow meme stocks AMC and GameStop are also snapped long win streaks

Shares of Bed Bath & Beyond Inc. tumbled Tuesday, to suffer their first decline in two weeks, after Baird analyst Justin Kleber suggested investors sell, saying the latest "meme stock frenzy" comes despite continued liquidity concerns.

Baird's Kleber turned bearish on the home goods retailer after its stock (BBBY) soared 39.8% on Monday, as the Reddit Wall Street Bets group appeared to be embracing the stock again, and rocketed 148.0% amid a nine-day win streak, which was the longest such streak since the 11-day stretch that ended Jan. 18, 2007.

The stock slumped 14.2% to close at $9.79 on Tuesday, but pared an intraday loss of as much as 24.4%.

Shares of AMC Entertainment Holdings Inc. (AMC) and GameStop Corp. (GME) stocks also pulled back Tuesday after long win streaks, as the meme-stock resurgence appeared to take a breather.

See Now: Bed Bath & Beyond leads rally in 'meme' stocks as Reddit group appears to be jumping back on board

The recent rally in Bed Bath & Beyond's stock (BBBY) comes even as the retailer continues to wrestle with a liquidity issues and falling revenue. For its recent fiscal first quarter, the company reported in late June sales of $1.46 billion, down from $1.95 billion in the year ago quarter, and below expectations of $1.51 billion. The company ended the quarter with cash and cash equivalents of $107.5 million, compared with $1.097 billion in the same period last year. The company also announced the ouster of chief executive officer Mark Tritton after less than three years at the company's helm.

Baird's Kleber downgraded Bed Bath & Beyond on Tuesday to underperform, after being at neutral since January 2021, citing valuation and the company's liquidity and market share losses.

"Shares have surged 148% since July 27, including +86% the past two trading days," Kleber wrote, in a note released early Tuesday. "This frenzied move (>100% of the public float traded on Monday) has been driven by non-fundamentally focused market participants."

He kept his stock price target at $4, which implies 59% downside from Tuesday's close.

"We estimate BBBY would need to generate >$350M of Ebitda [earnings before interest, taxes, depreciation and amortization] by FY24E/FY25E (vs. our FY22E/FY23E of -$350M/-$148M) to justify the stock's current $2.3B enterprise value -- a tall order given the current macro/sector backdrop," Kleber wrote.

Bed Bath & Beyond's liquidity is increasingly in focus, according to the analyst. "BBBY has burned $825M in cash over the past five quarters, and we model another -$250M over the next three," he wrote.

See Now: AMC takes aim at massive debt burden with 'APE' special dividend

With Kleber's downgrade, more than half (10) of the 19 analysts surveyed by FactSet have the equivalent of sell ratings on Bed Bath & Beyond's stock, while only one analyst is bullish and eight are neutral.

Meanwhile, AMC shares slid 6.3% to $22.45 on Tuesday, after soaring 64.6% amid a six-day win streak through Monday. That marked the longest win streak since it shot up 55.9% over the eight-day stretch that ended on May 18, 2021 during a previous meme-stock frenzy.

The movie theater operator had announced last week that it will issue a special "APE" dividend, in the form of AMC Preferred Equity Units that will trade on the New York Stock Exchange.

And GameStop's stock dropped 7.1% to $40.37 on Tuesday, after running up 34.0% amid a nine-day win streak through Monday. That was consumer electronics retailer's longest stretch of gains since the 10-day streak that ended March 28, 2022, in which the stock leapt 142.7%.

The latest exchange data showed that short interest (bearish bets) in Bed Bath & Beyond's stock represented 46.4% of the public float, or shares available to trade, which compares with 18.7% for AMC and with 23.3% for GameStop.

Bed Bath & Beyond shares have fallen 32.9% this year, compared with the S&P 500 index's decline of 13.5%. AMC shares have declined 17.5% year to date while GameStop's stock has gained 8.8%.

--Tomi Kilgore contributed to this report.

-James Rogers


(END) Dow Jones Newswires

August 10, 2022 07:46 ET (11:46 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.